Intervention Review

Ribavirin with or without alpha interferon for chronic hepatitis C

  1. Lise Lotte Gluud1,*,
  2. Kim Krogsgaard2,
  3. Christian Gluud1

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 22 APR 2002

Assessed as up-to-date: 23 FEB 2002

DOI: 10.1002/14651858.CD002234.pub2


How to Cite

Gluud LL, Krogsgaard K, Gluud C. Ribavirin with or without alpha interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD002234. DOI: 10.1002/14651858.CD002234.pub2.

Author Information

  1. 1

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet,, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  2. 2

    H:S Hvidovre University Hospital 447, PhaseOneTrials A/S, Hvidovre, Denmark

*Lise Lotte Gluud, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet,, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. liselottegluud@yahoo.dk.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 22 APR 2002

SEARCH

 
Reason for withdrawal from publication

Due to the huge number of trials, this original review is split into two separate reviews: 'Ribavirin monotherapy for chronic hepatitis C' and 'Ribavirin plus interferon versus interferon for chronic hepatitis C'. Both of these reviews are now published in The Cochrane Library. To view the published versions of this article, please click the 'Other versions' tab.